Bionime Corporation (4737.TW)

TWD 55.0

(1.1%)

Inventory Summary of Bionime Corporation

  • Bionime Corporation's latest annual inventory in 2023 was 491.25 Million TWD , down -8.76% from previous year.
  • Bionime Corporation's latest quarterly inventory in 2024 Q1 was 481.57 Million TWD , down -1.97% from previous quarter.
  • Bionime Corporation reported annual inventory of 538.43 Million TWD in 2022, down -8.76% from previous year.
  • Bionime Corporation reported annual inventory of 590.15 Million TWD in 2021, up 13.47% from previous year.
  • Bionime Corporation reported quarterly inventory of 481.57 Million TWD for 2024 Q1, down -1.97% from previous quarter.
  • Bionime Corporation reported quarterly inventory of 528.04 Million TWD for 2023 Q3, down -7.67% from previous quarter.

Annual Inventory Chart of Bionime Corporation (2023 - 2009)

Historical Annual Inventory of Bionime Corporation (2023 - 2009)

Year Inventory Inventory Growth
2023 491.25 Million TWD -8.76%
2022 538.43 Million TWD -8.76%
2021 590.15 Million TWD 13.47%
2020 520.08 Million TWD 31.52%
2019 395.44 Million TWD -4.12%
2018 412.42 Million TWD 13.18%
2017 364.39 Million TWD 17.22%
2016 310.86 Million TWD -10.54%
2015 347.48 Million TWD 6.21%
2014 327.18 Million TWD 5.29%
2013 310.73 Million TWD 7.18%
2012 289.91 Million TWD -9.79%
2011 321.39 Million TWD 100.4%
2010 160.37 Million TWD 32.78%
2009 120.78 Million TWD 0.0%

Peer Inventory Comparison of Bionime Corporation

Name Inventory Inventory Difference
Nang Kuang Pharmaceutical Co., Ltd. 705.32 Million TWD 30.35%
Maxigen Biotech Inc. 85.18 Million TWD -476.697%
SciVision Biotech Inc. 87.25 Million TWD -463.035%
Pegavision Corporation 583.47 Million TWD 15.805%
Visco Vision Inc. 606.06 Million TWD 18.943%